Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2C | P18825 | 1/20 | 0.55 |
| ▸ | AR | P10275 | 2/20 | 0.50 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.49 |
| ▸ | HTR7 | P34969 | 3/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
| ▸ | HTR1A | P08908 | 1/20 | 0.46 |
| ▸ | BRD4 | O60885 | 1/20 | 0.46 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.44 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.44 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.44 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.44 |
| ▸ | PGR | P06401 | 1/20 | 0.44 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.44 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.44 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.43 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.43 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.43 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.43 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20407070 | 0.91 | PGR (0.49) | ADRA2CARCLK4MAOBGABRG2 | |
| SCHEMBL996127 | 0.86 | ADRA2C (0.64) | ADRA2CCLK4MAOBGABRG2GABRB3 | |
| SCHEMBL21189094 | 0.86 | ADRA2C (0.49) | ADRA2CARCLK4MAOBBRD4 | |
| SCHEMBL18406713 | 0.85 | AR (0.49) | ADRA2CARHTR7HTR1A | |
| SCHEMBL3422474 | 0.82 | ADRA2C (0.60) | ADRA2CCLK4MAOBGABRG2GABRB3 | |
| SCHEMBL31272452 | 0.82 | ADRA2C (0.60) | ADRA2CCLK4MAOBGABRG2GABRB3 | |
| SCHEMBL14850862 | 0.82 | CLK4 (0.46) | ADRA2CARCLK4MAOBBRD4 | |
| SCHEMBL20407091 | 0.81 | PGR (0.47) | ADRA2CARCLK4GABRG2GABRB3 | |
| SCHEMBL16905206 | 0.81 | CLK4 (0.52) | ADRA2CARCLK4MAOBPGR | |
| SCHEMBL23625538 | 0.81 | ADRA2C (0.48) | ADRA2CARCLK4MAOBBRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230210000-A1 | COMPOUND, LIGHT EMITTING MATERIAL, AND LIGHT EMITTING DEVICE | KYULUX, INC. (JP) | 2023-06-29 | — | — | US | disclosed |
| US-20200194681-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO LTD (KR) | 2020-06-18 | — | — | US | disclosed |
| US-10615348-B2 | Organic light-emitting device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-04-07 | — | — | US | disclosed |
| US-20190229276-A1 | CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-07-25 | — | — | US | disclosed |
| US-10193082-B2 | Condensed-cyclic compound and organic light emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-01-29 | — | — | US | disclosed |
| US-10043983-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2018-08-07 | — | — | US | disclosed |
| US-10043983-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2018-08-07 | — | — | US | disclosed |
| US-20170141323-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-05-18 | — | — | US | disclosed |
| US-20170054082-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-02-23 | — | — | US | disclosed |
| US-20170025620-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-01-26 | — | — | US | disclosed |
| US-20170025620-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-01-26 | — | — | US | disclosed |
| EP-3029026-A1 | NOVEL BIPHENYL DERIVATIVE AND METHOD FOR PREPARING SAME | Dong-A ST Co., Ltd. (KR) | 2016-06-08 | — | — | EP | disclosed |
| US-8148535-B2 | Potassium channel inhibitors | MERCK SHARP & DOHME CORP. (US) | 2012-04-03 | — | — | US | disclosed |
| US-20090275581-A1 | RENIN INHIBITORS | VITAE PHARMACEUTICALS, INC. | 2009-11-05 | — | — | US | disclosed |
| US-20090233897-A1 | Potassium Channel Inhibitors | MERCK SHARP & DOHME CORP. | 2009-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10043983-B2 | Condensed cyclic compound and organic light-emitting device including the same | CRY1, CCNE1, CRY2 | ADRA2C 3380/4885AR 3051/4885CLK4 1693/4885 |
| US-20190229276-A1 | CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND | CRY1, CCNT1, CCND2 | ADRA2C 1207/4885AR 107/4885CLK4 928/4885 |
| US-20090275581-A1 | RENIN INHIBITORS | REN, ACE, SERPINB1 | ADRA2C 614/4885AR 3656/4885CLK4 4398/4885 |
| US-10193082-B2 | Condensed-cyclic compound and organic light emitting device including the same | CRY1, CNOT9, CNOT1 | ADRA2C 1803/4885AR 456/4885CLK4 1799/4885 |
| US-20230210000-A1 | COMPOUND, LIGHT EMITTING MATERIAL, AND LIGHT EMITTING DEVICE | DRD1, DRD2, DRD3 | ADRA2C 559/4885AR 295/4885CLK4 571/4885 |
| US-20170025620-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CCNE1, CRY2 | ADRA2C 3380/4885AR 3051/4885CLK4 1693/4885 |
| US-20170054082-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | CRY1, CNOT9, CNOT1 | ADRA2C 1803/4885AR 456/4885CLK4 1799/4885 |
| US-20090233897-A1 | Potassium Channel Inhibitors | KCNJ2, KCNQ2, KCNH2 | ADRA2C 717/4885AR 4159/4885CLK4 964/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.